Sort
326,823 grants matching “clinical trial”
RETAIN: A digital therapeutic for Alzheimer's risk reduction
$1,644,444Mark McInnis · Retain Health Inc · R44 · FY2022 · AG
ADVANCED TECHNOLOGY QA CENTER
$1,644,353Washington University · U24 · FY2005 · CA
ALACRITY for Early Screening and Treatment of High Risk Youth (eSToRY)
$1,644,256Benjamin Le Cook · Cambridge Health Alliance · P50 · FY2023 · MH
NCORP of the Carolinas (Greenville Health System NCORP)
$1,644,191Ki Young Chung · Prisma Health - Upstate · UG1 · FY2021 · CA
Child and Adolescent Psychiatry Trials Network (CAPTN)
$1,644,148Duke University · P30 · FY2004 · MH
Treatments For Complex Patients In New Settings
$1,644,129Sharon M. Hall · University Of California, San Francisco · P50 · FY2007 · DA
GENE AND PHARMACOLOGICAL THERAPIES FOR CYSTIC FIBROSIS
$1,644,018Johns Hopkins University · P01 · FY2000 · HL
WARFARIN ANTIPLATELET RECURRENT STROKE STUDY
$1,643,937Columbia University Health Sciences · R01 · FY2001 · NS
Improving Advance Care Planning in Oncology: A Pragmatic, Cluster-Randomized Trial Integrating Patient Videos and Clinician Communication Training
$1,643,692James Aaron Tulsky · Dana-Farber Cancer Inst · UH3 · FY2022 · AG
ALZHEIMER DISEASE RESEARCH CENTER
$1,643,678University Of Southern California · P50 · FY2003 · AG
Prostaglandin inhibition for emphysema
$1,643,595Stephen Rennard Rennard · University Of Nebraska Medical Center · UM1 · FY2014 · HL
Ancillary Study
$1,643,595Stephen Rennard Rennard · University Of Nebraska Medical Center · UM1 · FY2014 · HL
ADULT AIDS CLINICAL TRIALS UNIT
$1,643,516University Of Washington · U01 · FY2003 · AI
Tumor Hypoxia: Molecular Studies & Clinical Exploitation
$1,643,350Amato J. Giaccia · Stanford University · P01 · FY2009 · CA
IMPACT: Integrative Mindfulness-Based Predictive Approach for Chronic low back pain Treatment
$1,643,228Jean A King · Worcester Polytechnic Institute · UG3 · FY2023 · NS
SPIRRIT-HFPEF - CCC
$1,643,083Eric David Peterson · Duke University · U01 · FY2018 · HL
Therapeutic Targeting of Carotid Body Chemoreflex for Sleep Disordered Breathing
$1,643,080Nanduri R Prabhakar · University Of Chicago · UH2 · FY2015 · HL
Center to Accelerate Translation of Interventions to Decrease Premature Mortality in SMI
$1,642,990Gail L Daumit · Johns Hopkins University · P50 · FY2018 · MH
ADULT AIDS CLINICAL TRIALS GROUP
$1,642,975University Of Alabama At Birmingham · U01 · FY2005 · AI
NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical Program
$1,642,936Lorenzo Leggio · National Institute On Drug Abuse · ZID · FY2022 · DA
Pulmonary Hypertension in SCD
$1,642,787Marilyn J Telen · Duke University · R01 · FY2006 · HL
Human AME study of CT1812, a small molecule in phase 2 clinical trials for the treatment of Alzheimer's disease
$1,642,783Anthony O Caggiano · Cognition Therapeutics, Inc. · SB1 · FY2021 · AG
Etiology and Treatment of Alcohol Dependence
$1,642,705Lance O. Bauer · University Of Connecticut Sch Of Med/Dnt · P50 · FY2019 · AA
National AIDS Research Institute (NARI), Pune, INDIA: Clinical Trials Unit
$1,642,668Sheela Virendra Godbole · National Aids Research Institute · UM1 · FY2013 · AI
Experimental Animal Models of TB: Chemotherapeutics and Imaging
$1,642,641Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI